Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

ALEC – Alector Inc.

ALEC — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

7.29

Margin Of Safety %

Put/Call OI Ratio

0.06

EPS Next Q Diff

-0.02

EPS Last/This Y

0.51

EPS This/Next Y

0.18

Price

1.77

Target Price

3.1

Analyst Recom

2.86

Performance Q

-27.05

Upside

-2,243.3%

Beta

0.62

Ticker: ALEC




20 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-07-13ALEC1.520.370.4912372
2026-07-14ALEC1.370.385.0712403
2026-07-15ALEC1.50.330.0012018
2026-07-16ALEC1.480.330.0012017
2026-07-17ALEC1.5050.330.0012017
2026-07-20ALEC1.4320.050.001753
2026-07-21ALEC1.5350.050.001759
2026-07-22ALEC1.5280.050.001830
2026-07-23ALEC1.50.050.001885
2026-07-24ALEC1.490.050.001925
2026-07-27ALEC1.520.050.001927
2026-07-28ALEC1.510.050.001929
2026-07-29ALEC1.5150.050.001929
2026-07-30ALEC1.630.050.622019
2026-07-31ALEC1.510.090.002199
2026-08-03ALEC1.520.090.002257
2026-08-04ALEC1.540.090.002334
2026-08-05ALEC1.4850.090.002389
2026-08-06ALEC1.860.060.063437
2026-08-07ALEC1.780.060.503747
DateSymbolLatestP/C OIP/C VolTotal OI
20 items Current Page1 of 1




20 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-07-13ALEC1.5123.9- -0.88
2026-07-14ALEC1.3823.9- -0.88
2026-07-15ALEC1.5023.9- -0.88
2026-07-16ALEC1.4823.9- -0.88
2026-07-17ALEC1.5123.9- -0.88
2026-07-20ALEC1.4323.9- -0.88
2026-07-21ALEC1.5323.9- -0.88
2026-07-22ALEC1.5323.9- -0.88
2026-07-23ALEC1.5023.9- -0.88
2026-07-24ALEC1.4823.9- -0.88
2026-07-27ALEC1.5223.9- -0.88
2026-07-28ALEC1.5123.9- -0.88
2026-07-29ALEC1.5223.9- -0.88
2026-07-30ALEC1.6223.9- -0.88
2026-07-31ALEC1.5123.9- -0.88
2026-08-03ALEC1.5223.9- -0.88
2026-08-04ALEC1.5223.9- -0.88
2026-08-05ALEC1.4823.9- -0.88
2026-08-06ALEC1.8723.9- -0.88
2026-08-07ALEC1.7723.9- -0.88
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
20 items Current Page1 of 1




20 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-07-13ALEC-0.731.337.35
2026-07-14ALEC-0.731.337.35
2026-07-15ALEC-0.731.337.35
2026-07-16ALEC-0.731.337.35
2026-07-17ALEC-0.731.337.35
2026-07-20ALEC-0.731.187.35
2026-07-21ALEC-0.731.187.35
2026-07-22ALEC-0.731.187.35
2026-07-23ALEC-0.731.187.35
2026-07-24ALEC-0.731.187.35
2026-07-27ALEC-0.731.187.29
2026-07-28ALEC-0.731.187.29
2026-07-29ALEC-0.731.187.29
2026-07-30ALEC-0.731.187.29
2026-07-31ALEC-0.731.187.29
2026-08-03ALEC-0.731.117.29
2026-08-04ALEC-0.731.117.29
2026-08-05ALEC-0.731.117.29
2026-08-06ALEC-0.731.117.29
2026-08-07ALEC-0.731.117.29
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
20 items Current Page1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

-0.23

Avg. EPS Est. Next Quarter

-0.23

Insider Transactions

-0.73

Institutional Transactions

1.11

Beta

0.62

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

1

Fair Value

Quality Score

4

Growth Score

32

Sentiment Score

54

Actual DrawDown %

93.9

Max Drawdown 5-Year %

-96.8

Target Price

3.1

P/E

Forward P/E

PEG

P/S

14.26

P/B

19.04

P/Free Cash Flow

EPS

-1.09

Average EPS Est. Cur. Y​

-0.88

EPS Next Y. (Est.)

-0.7

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-850.13

Relative Volume

1.58

Return on Equity vs Sector %

-100

Return on Equity vs Industry %

-100

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

ALEC Healthcare
$1.78
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
6/20
Pullback
4/25
Volume
3/15
Valuation
12/20
TP/AR
2/10
Options
8/10
RSI
57.9
Range 1M
60.9%
Sup Dist
14.1%
🚀
Momentum Growth
Ride accelerating trends
N/A
37 /100
WEAK
Momentum
3/25
Growth
17/30
Estimates
2/20
Inst/Vol
7/15
Options
8/10
EPS Yr
38.3%
EPS NY
24.2%
52W%
29.7%
💎
Long-Term Value
Quality companies, undervalued
N/A
0 /100
WEAK
🟢 BUY +74.2% upside
Quality
6/30
Valuation
14/30
Growth
19/25
Stability
8/10
LT Trend
1/5
Upside
+74.2%
Quality
4
ALEC — P/E HistoricalBiotechnology
Alector, Inc.
Sector: Healthcare
Industry: Biotechnology
Employees: 103
Alector, Inc., a clinical stage biotechnology company, develops therapies to counteract the progression of neurodegeneration in the United States. Its pipeline includes Nivisnebart, an investigational human recombinant monoclonal antibody for treating prevalent neurodegenerative diseases; AL137, an anti-amyloid beta antibody paired in preclinical development for the potential treatment of Alzheimer's disease; and AL050, a GCase enzyme replacement therapy in preclinical development for the potential treatment of Parkinson's disease and Lewy body dementia in patients having GBA1 gene mutations. The company also develops its preclinical and research pipeline comprising AL064, a tau siRNA for Alzheimer's disease and other tauopathies; ADP062-ABC, an alpha-synuclein siRNA for Parkinson's disease; and ADP065-ABC, an NLRP3 siRNA for neurodegenerative conditions. It has a strategic collaboration agreement with GlaxoSmithKline plc for the development and commercialization of progranulin-elevating monoclonal antibodies, including Latozinemab and Nivisnebart. The company was founded in 2013 and is headquartered in South San Francisco, California.
ALEC

Latest News

Caricamento notizie per ALEC
stock quote shares ALEC – Alector Inc. Stock Price stock today
news today ALEC – Alector Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch ALEC – Alector Inc. yahoo finance google finance
stock history ALEC – Alector Inc. invest stock market
stock prices ALEC premarket after hours
ticker ALEC fair value insiders trading